{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:50:15Z","timestamp":1793375415905,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bio\/chemoinformatics tools can be deployed to compare antimicrobial agents aiming to select an efficient nose-to-brain formulation targeting the meningitis disease by utilizing the differences in the main structural, topological and electronic descriptors of the drugs. Cefotaxime and ceftriaxone were compared at the formulation level (by comparing the loading in gelatin and tripalmitin matrices as bases for the formation of nanoparticulate systems), at the biopharmaceutical level (through the interaction with mucin and the P-gp efflux pumps) and at the therapeutic level (through studying the interaction with<jats:italic>S. pneumoniae<\/jats:italic>bacterial receptors). GROMACS v4.6.5 software package was used to carry-out all-atom molecular dynamics simulations. Higher affinity of ceftriaxone was observed compared to cefotaxime on the investigated biopharmaceutical and therapeutic macromolecules. Both drugs showed successful docking on mucin, P-gp efflux pump and<jats:italic>S. pneumoniae<\/jats:italic>PBP1a and 2b; but ceftriaxone showed higher affinity to the P-gp efflux pump proteins and higher docking on mucin. Ceftriaxone showed less out-of-matrix diffusion and higher entrapment on the gelatin and the tripalmitin matrices. Accordingly, Ceftriaxone gelatin nanospheres or tripalmitin solid lipid nanoparticles may pose a more feasible and efficient nose-to-brain formulation targeting the meningitis disease compared to the cefotaxime counterparts.<\/jats:p>","DOI":"10.1038\/s41598-020-78327-w","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T11:06:08Z","timestamp":1607079968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Comparing cefotaxime and ceftriaxone in combating meningitis through nose-to-brain delivery using bio\/chemoinformatics tools"],"prefix":"10.1038","volume":"10","author":[{"given":"Rania M.","family":"Hathout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherihan G.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir S.","family":"El-Housseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkader A.","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"78327_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s12879-019-4204-z","volume":"19","author":"M Troendle","year":"2019","unstructured":"Troendle, M. & Pettigrew, A. A systematic review of cases of meningitis in the absence of cerebrospinal fluid pleocytosis on lumbar puncture. BMC Infect. Dis. 19, 692 (2019).","journal-title":"BMC Infect. Dis."},{"key":"78327_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7861\/clinmedicine.18-2-164","volume":"18","author":"MJ Griffiths","year":"2018","unstructured":"Griffiths, M. J., McGill, F. & Solomon, T. Management of acute meningitis. Clin. Med. (Lond.) 18, 164\u2013169 (2018).","journal-title":"Clin. Med. (Lond.)"},{"key":"78327_CR3","doi-asserted-by":"publisher","first-page":"e0198772","DOI":"10.1371\/journal.pone.0198772","volume":"13","author":"AM Oordt-Speets","year":"2018","unstructured":"Oordt-Speets, A. M., Bolijn, R., van Hoorn, R. C., Bhavsar, A. & Kyaw, M. H. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PLoS\u00a0One 13, e0198772 (2018).","journal-title":"PLoS\u00a0One"},{"key":"78327_CR4","doi-asserted-by":"publisher","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","volume":"2","author":"BDM van de Brouwer","year":"2016","unstructured":"van de Brouwer, B. D. M., Hasbun, R., Koedel, U., Whitney, C. G. & Wijdicks, E. Community-acquired bacterial meningitis. Nat. Rev. Dis. Primers. 2, 16074 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"78327_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/adc.88.7.615","volume":"88","author":"BH El","year":"2003","unstructured":"El, B. H., Laundy, M. & Booy, R. Diagnosis and treatment of bacterial meningitis. Arch. Dis. Child 88, 615\u2013620 (2003).","journal-title":"Arch. Dis. Child"},{"key":"78327_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000007106","volume":"44","author":"H Scholz","year":"1998","unstructured":"Scholz, H., Hofmann, T., Noack, R., Edwards, D. J. & Stoeckel, K. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy 44, 142\u2013147 (1998).","journal-title":"Chemotherapy"},{"key":"78327_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1574-6976.2008.00105.x","volume":"32","author":"E Sauvage","year":"2008","unstructured":"Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A. & Charlier, P. The penicillin-binding proteins: Structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 234\u2013258 (2008).","journal-title":"FEMS Microbiol. Rev."},{"key":"78327_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1574-6976.2006.00024.x","volume":"30","author":"P Macheboeuf","year":"2006","unstructured":"Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O. & Dessen, A. Penicillin binding proteins: Key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol. Rev. 30, 673\u2013691 (2006).","journal-title":"FEMS Microbiol. Rev."},{"key":"78327_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/mmi.12408","volume":"90","author":"AD Land","year":"2013","unstructured":"Land, A. D. et al. Requirement of essential Pbp2x and GpsB for septal ring closure in Streptococcus pneumoniae D39. Mol Microbiol. 90, 939\u2013955 (2013).","journal-title":"Mol Microbiol."},{"key":"78327_CR10","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1111\/1462-2920.12189","volume":"15","author":"O Massidda","year":"2013","unstructured":"Massidda, O., Novakova, L. & Vollmer, W. From models to pathogens: How much have we learned about Streptococcus pneumoniae cell division?. Environ. Microbiol. 15, 3133\u20133157 (2013).","journal-title":"Environ. Microbiol."},{"key":"78327_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/fmb.12.2","volume":"7","author":"R Hakenbeck","year":"2012","unstructured":"Hakenbeck, R., Bruckner, R., Denapaite, D. & Maurer, P. Molecular mechanisms of beta-lactam resistance in Streptococcus pneumoniae. Future. Microbiol. 7, 395\u2013410 (2012).","journal-title":"Future. Microbiol."},{"key":"78327_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/mmi.12745","volume":"94","author":"HT Tsui","year":"2014","unstructured":"Tsui, H. T. et al. Pbp2x localizes separately from Pbp2b and other peptidoglycan synthesis proteins during later stages of cell division of Streptococcus pneumoniae D39. Mol Microbiol. 94, 21\u201340 (2014).","journal-title":"Mol Microbiol."},{"key":"78327_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000007170","volume":"45","author":"R Hakenbeck","year":"1999","unstructured":"Hakenbeck, R. beta-lactam-resistant Streptococcus pneumoniae: Epidemiology and evolutionary mechanism. Chemotherapy 45, 83\u201394 (1999).","journal-title":"Chemotherapy"},{"key":"78327_CR14","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/AAC.48.10.4020-4022.2004","volume":"48","author":"K Kosowska","year":"2004","unstructured":"Kosowska, K., Jacobs, M. R., Bajaksouzian, S., Koeth, L. & Appelbaum, P. C. Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs. Antimicrob. Agents Chemother. 48, 4020\u20134022 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78327_CR15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.46.5.1273-1280.2002","volume":"46","author":"K Nagai","year":"2002","unstructured":"Nagai, K., Davies, T. A., Jacobs, M. R. & Appelbaum, P. C. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob. Agents Chemother. 46, 1273\u20131280 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78327_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/mdr.1996.2.177","volume":"2","author":"P Reichmann","year":"1996","unstructured":"Reichmann, P., Konig, A., Marton, A. & Hakenbeck, R. Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae. Microb. Drug Resist. 2, 177\u2013181 (1996).","journal-title":"Microb. Drug Resist."},{"key":"78327_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1128\/AAC.40.1.218","volume":"40","author":"PF Viladrich","year":"1996","unstructured":"Viladrich, P. F. et al. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 40, 218\u2013220 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"78327_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11481-006-9039-x","volume":"2","author":"LR Hanson","year":"2007","unstructured":"Hanson, L. R. & Frey, W. H. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune. Pharmacol. 2, 81\u201386 (2007).","journal-title":"J Neuroimmune. Pharmacol."},{"key":"78327_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2017.11.041","volume":"270","author":"L Godfrey","year":"2018","unstructured":"Godfrey, L. et al. Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia. J. Control Release 270, 135\u2013144 (2018).","journal-title":"J. Control Release"},{"key":"78327_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1124\/jpet.119.258152","volume":"370","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Xiong, G., Tsang, W. C., Sch\u00f1tzlein, A. G. & Uchegbu, I. F. Nose-to-brain delivery. J. Pharmacol. Exp. Ther. 370, 593 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"78327_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12859-017-1640-x","volume":"18","author":"GE Heo","year":"2017","unstructured":"Heo, G. E., Kang, K. Y., Song, M. & Lee, J. H. Analyzing the field of bioinformatics with the multi-faceted topic modeling technique. BMC Bioinform. 18, 251 (2017).","journal-title":"BMC Bioinform."},{"key":"78327_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bib\/bbn014","volume":"9","author":"MP Lefranc","year":"2008","unstructured":"Lefranc, M. P., Giudicelli, V., Regnier, L. & Duroux, P. IMGT, a system and an ontology that bridge biological and computational spheres in bioinformatics. Brief. Bioinform. 9, 263\u2013275 (2008).","journal-title":"Brief. Bioinform."},{"key":"78327_CR23","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1080\/14786419.2017.1385017","volume":"32","author":"RM Hathout","year":"2018","unstructured":"Hathout, R. M., El-Ahmady, S. H. & Metwally, A. A. Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio\/chemo-informatics case study. Nat. Prod. Res 32, 2873\u20132881 (2018).","journal-title":"Nat. Prod. Res"},{"key":"78327_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/2229-3485.184782","volume":"7","author":"SK Gill","year":"2016","unstructured":"Gill, S. K., Christopher, A. F., Gupta, V. & Bansal, P. Emerging role of bioinformatics tools and software in evolution of clinical research. Perspect. Clin. Res 7, 115\u2013122 (2016).","journal-title":"Perspect. Clin. Res"},{"key":"78327_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fphar.2018.00923","volume":"9","author":"V Salmaso","year":"2018","unstructured":"Salmaso, V. & Moro, S. Bridging molecular docking to molecular dynamics in exploring ligand\u2013protein recognition process: An overview. Front. Pharmacol. 9, 923 (2018).","journal-title":"Front. Pharmacol."},{"key":"78327_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845\u2013854 (2013).","journal-title":"Bioinformatics"},{"key":"78327_CR27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"78327_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/cbdd.12295","volume":"84","author":"M Gooding","year":"2014","unstructured":"Gooding, M. et al. A bifurcated proteoglycan binding small molecule carrier for siRNA delivery. Chem. Biol. Drug Des. 84, 24\u201335 (2014).","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"78327_CR29","first-page":"76","volume":"2009","author":"AD Costache","year":"2009","unstructured":"Costache, A. D., Sheihet, L., Knight, D. D. & Kohn, J. Modeling of polymer-drug interactions in biodegradable tyrosine-based nanospheres using molecular dynamics simulations and docking. NSTI-Nanotech 2009(2), 76\u201378 (2009).","journal-title":"NSTI-Nanotech"},{"issue":"Suppl 17","key":"78327_CR30","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2105-13-S17-S5","volume":"13","author":"M Elhefnawi","year":"2012","unstructured":"Elhefnawi, M., ElGamacy, M. & Fares, M. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: Structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors. BMC Bioinform. 13(Suppl 17), S5 (2012).","journal-title":"BMC Bioinform."},{"key":"78327_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/biomedicines8010013","volume":"8","author":"S Shakeri","year":"2020","unstructured":"Shakeri, S. et al. Multifunctional polymeric nanoplatforms for brain diseases diagnosis, therapy and theranostics. Biomedicines 8, 20 (2020).","journal-title":"Biomedicines"},{"key":"78327_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2019.09.017","volume":"519","author":"H He","year":"2019","unstructured":"He, H. et al. Solid lipid nanoparticles as a drug delivery system to across the blood\u2013brain barrier. Biochem. Biophys. Res. Commun. 519, 385\u2013390 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"78327_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1080\/10837450.2019.1667386","volume":"24","author":"SA El-Gizawy","year":"2019","unstructured":"El-Gizawy, S. A., El-Maghraby, G. M. & Hedaya, A. A. Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study. Pharm. Dev. Technol. 24, 1299\u20131307 (2019).","journal-title":"Pharm. Dev. Technol."},{"key":"78327_CR34","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.phymed.2016.10.020","volume":"23","author":"AA Metwally","year":"2016","unstructured":"Metwally, A. A., El-Ahmady, S. H. & Hathout, R. M. Selecting optimum protein nano-carriers for natural polyphenols using chemoinformatics tools. Phytomedicine 23, 1764\u20131770 (2016).","journal-title":"Phytomedicine"},{"key":"78327_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ejpb.2016.07.019","volume":"108","author":"RM Hathout","year":"2016","unstructured":"Hathout, R. M. & Metwally, A. A. Towards better modelling of drug-loading in solid lipid nanoparticles: Molecular dynamics, docking experiments and Gaussian Processes machine learning. Eur. J. Pharm. Biopharm. 108, 262\u2013268 (2016).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"78327_CR36","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1021\/mp500740d","volume":"12","author":"AA Metwally","year":"2015","unstructured":"Metwally, A. A. & Hathout, R. M. Computer-assisted drug formulation design: Novel approach in drug delivery. Mol. Pharm. 12, 2800\u20132810 (2015).","journal-title":"Mol. Pharm."},{"issue":"3","key":"78327_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1021\/acsomega.9b03487","volume":"5","author":"RM Hathout","year":"2020","unstructured":"Hathout, R. M., Metwally, A. A., Woodman, T. J. & Hardy, J. G. Prediction of drug loading in the gelatin matrix using computational methods. ACS Omega 5(3), 1549\u20131556 (2020).","journal-title":"ACS Omega"},{"key":"78327_CR38","doi-asserted-by":"publisher","first-page":"11293","DOI":"10.1021\/acsomega.9b01580","volume":"4","author":"M Ossama","year":"2019","unstructured":"Ossama, M., Hathout, R. M., Attia, D. A. & Mortada, N. D. Enhanced allicin cytotoxicity on HEPG-2 cells using glycyrrhetinic acid surface-decorated gelatin nanoparticles. ACS Omega 4, 11293\u201311300 (2019).","journal-title":"ACS Omega"},{"key":"78327_CR39","first-page":"71","volume":"2019","author":"RM Hathout","year":"2000","unstructured":"Hathout, R. M. & Metwally, A. A. Gelatin nanoparticles. Methods Mol. Biol. 2019, 71\u201378 (2000).","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"78327_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jfb10020026","volume":"10","author":"M Hill","year":"2019","unstructured":"Hill, M. et al. Formulation of antimicrobial tobramycin loaded PLGA nanoparticles via complexation with AOT. J. Funct. Biomater. 10(2), 26 (2019).","journal-title":"J. Funct. Biomater."},{"key":"78327_CR41","first-page":"20","volume":"11","author":"SAA Shah","year":"2018","unstructured":"Shah, S. A. A. et al. Electrochemically enhanced drug delivery using polypyrrole films. Mater. Basel 11, 20 (2018).","journal-title":"Mater. Basel"},{"key":"78327_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2012.04.032","volume":"161","author":"RM Hathout","year":"2012","unstructured":"Hathout, R. M. & Woodman, T. J. Applications of NMR in the characterization of pharmaceutical microemulsions. J. Control. Release 161, 62\u201372 (2012).","journal-title":"J. Control. Release"},{"key":"78327_CR43","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.bbamem.2016.02.028","volume":"1858","author":"M Ramezanpour","year":"2016","unstructured":"Ramezanpour, M. et al. Computational and experimental approaches for investigating nanoparticle-based drug delivery systems. Biochim. Biophys. Acta 1858, 1688\u20131709 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"78327_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cherd.2015.09.003","volume":"104","author":"AA Metwally","year":"2015","unstructured":"Metwally, A. A. & Hathout, R. M. Replacing microemulsion formulations experimental solubility studies with in-silico methods comprising molecular dynamics and docking experiments. Chem. Eng. Res. Des. 104, 453\u2013456 (2015).","journal-title":"Chem. Eng. Res. Des."},{"key":"78327_CR45","doi-asserted-by":"crossref","unstructured":"Hathout, R. M., Abdelhamid, S. G. & Metwally, A. A. Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio\/chemoinformatics tools. Inform. Med. Unlocked 21, 100446 (2020).","DOI":"10.1016\/j.imu.2020.100446"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78327-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78327-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78327-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T17:29:11Z","timestamp":1698427751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78327-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78327"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78327-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21250"}}